1-(3-fluoro-4-methoxyphenyl)cyclopropan-1-amine

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 1-(3-fluoro-4-methoxyphenyl)cyclopropan-1-amine
• 化学式: C₁₀H₁₂FNO
• mdl: MFCD11037211
• 分子量: 181.21
• InChiKey: UEPDZTQWKXHIFN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-(3-fluoro-4-methoxyphenyl)cyclopropan-1-amine 在 甲醇 、 sodium tetrahydroborate 、 对甲苯磺酸 作用下， 以 甲苯 为溶剂， 反应 12.0h， 生成 N-(1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)ethyl)-1-(3-fluoro-4-methoxyphenyl)cyclopropan-1-amine
  参考文献：
  名称：

  Studies on Dibenzylamines as Inhibitors of Venezuelan Equine Encephalitis Virus

  摘要：

  Alphaviruses are arthropod-transmitted members of the Togaviridae family that can cause severe disease in humans, including debilitating arthralgia and severe neurological complications. Currently, there are no approved vaccines or antiviral therapies directed against the alphaviruses, and care is limited to treating disease symptoms. A phenotypic cell-based high-throughput screen was performed to identify small molecules that inhibit the replication of Venezuelan Equine Encephalitis Virus (VEEV). The compound, 1-(2,3-dihydrobenzo [b] [1,4] dioxin-6-yl)-N-(3-fluoro-4-methoxybenzyl)ethan-1-amine (1), was identified as a highly active, potent inhibitor of VEEV with an effective concentration for 90% inhibition of virus (EC90) of 0.89 mu M and 7.49 log reduction in virus titers at 10 mu M concentration. These data suggest that further investigation of compound 1 as an antiviral therapeutic against VEEV, and perhaps other alphaviruses, is warranted. Experiments suggested that the antiviral activity of compound 1 is directed at an early step in the VEEV replication cycle by blocking viral RNA and protein synthesis.

  DOI：

  10.1021/acsinfecdis.9b00035
• 作为产物：
  描述：

  3-氟-4-甲氧基苯腈 、 乙基溴化镁 在 titanium(IV) isopropylate 、 三氟化硼乙醚 作用下， 以 乙醚 为溶剂， 反应 2.17h， 以25%的产率得到1-(3-fluoro-4-methoxyphenyl)cyclopropan-1-amine
  参考文献：
  名称：

  Studies on Dibenzylamines as Inhibitors of Venezuelan Equine Encephalitis Virus

  摘要：

  Alphaviruses are arthropod-transmitted members of the Togaviridae family that can cause severe disease in humans, including debilitating arthralgia and severe neurological complications. Currently, there are no approved vaccines or antiviral therapies directed against the alphaviruses, and care is limited to treating disease symptoms. A phenotypic cell-based high-throughput screen was performed to identify small molecules that inhibit the replication of Venezuelan Equine Encephalitis Virus (VEEV). The compound, 1-(2,3-dihydrobenzo [b] [1,4] dioxin-6-yl)-N-(3-fluoro-4-methoxybenzyl)ethan-1-amine (1), was identified as a highly active, potent inhibitor of VEEV with an effective concentration for 90% inhibition of virus (EC90) of 0.89 mu M and 7.49 log reduction in virus titers at 10 mu M concentration. These data suggest that further investigation of compound 1 as an antiviral therapeutic against VEEV, and perhaps other alphaviruses, is warranted. Experiments suggested that the antiviral activity of compound 1 is directed at an early step in the VEEV replication cycle by blocking viral RNA and protein synthesis.

  DOI：

  10.1021/acsinfecdis.9b00035

文献信息

• [EN] MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS<br/>[FR] ANTAGONISTES DES RÉCEPTEURS MUSCARINIQUES DE L'ACÉTYLCHOLINE M1
  申请人：PIPELINE THERAPEUTICS INC

  公开号：WO2021071843A1

  公开（公告）日：2021-04-15

  Provided herein, inter alia, are compounds which are useful as antagonists of the muscarinic acetylcholine receptor M1 (mAChR M1); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions.

  本文提供了一些化合物，这些化合物可用作胆碱能乙酰胆碱受体M1（mAChR M1）的拮抗剂；制备这些化合物的合成方法；包含这些化合物的药物组合物；以及使用这些化合物和组合物治疗与胆碱能乙酰胆碱受体功能障碍相关的神经和精神疾病的方法。
• Studies on Dibenzylamines as Inhibitors of Venezuelan Equine Encephalitis Virus
  作者：Theresa H. Nguyen、Nicole N. Haese、Nikhil Madadi、Sanjay Sarkar、Kiley Bonin、Cassilyn E. Streblow、Sharon Taft-Benz、Nichole A. Tower、Lynn Rasmussen、Robert Bostwick、Corinne E. Augelli-Szafran、Mark J. Suto、Thomas E. Morrison、Victor DeFilippis、Mark T. Heise、Daniel N. Streblow、Ashish K. Pathak

  DOI：10.1021/acsinfecdis.9b00035

  日期：2019.12.13

  Alphaviruses are arthropod-transmitted members of the Togaviridae family that can cause severe disease in humans, including debilitating arthralgia and severe neurological complications. Currently, there are no approved vaccines or antiviral therapies directed against the alphaviruses, and care is limited to treating disease symptoms. A phenotypic cell-based high-throughput screen was performed to identify small molecules that inhibit the replication of Venezuelan Equine Encephalitis Virus (VEEV). The compound, 1-(2,3-dihydrobenzo [b] [1,4] dioxin-6-yl)-N-(3-fluoro-4-methoxybenzyl)ethan-1-amine (1), was identified as a highly active, potent inhibitor of VEEV with an effective concentration for 90% inhibition of virus (EC90) of 0.89 mu M and 7.49 log reduction in virus titers at 10 mu M concentration. These data suggest that further investigation of compound 1 as an antiviral therapeutic against VEEV, and perhaps other alphaviruses, is warranted. Experiments suggested that the antiviral activity of compound 1 is directed at an early step in the VEEV replication cycle by blocking viral RNA and protein synthesis.